6,469
Views
88
CrossRef citations to date
0
Altmetric
Research Article

Stability of Liposomal Formulations in Physiological Conditions for Oral Drug Delivery

, , &
Pages 123-128 | Published online: 19 Oct 2008

Figures & data

1 Stability of EPC/Chol (□), EPC/Chol/SM (○), EPC/Chol/SM/GM1 (♦), and EPC/Chol/SM/GM type III (dtrif;) liposomes in buffer Tes at 25°C (A) and 37°C (B) measured by the enzyme kinetics method. Each point represents mean values of experiments performed in triplicate. Percentage values varied less than ±5% between determinations.

1 Stability of EPC/Chol (□), EPC/Chol/SM (○), EPC/Chol/SM/GM1 (♦), and EPC/Chol/SM/GM type III (dtrif;) liposomes in buffer Tes at 25°C (A) and 37°C (B) measured by the enzyme kinetics method. Each point represents mean values of experiments performed in triplicate. Percentage values varied less than ±5% between determinations.

2 Stability of EPC/Chol (□), EPC/Chol/SM (○), EPC/Chol/SM/GM1 (♦), and EPC/Chol/SM/GM type III (▾) liposomes in plasma at 25°C (A) and 37°C (B) measured by the enzyme kinetics method. Each point represents mean values of experiments performed in triplicate. Percentage values varied less than ±5% between determinations.

2 Stability of EPC/Chol (□), EPC/Chol/SM (○), EPC/Chol/SM/GM1 (♦), and EPC/Chol/SM/GM type III (▾) liposomes in plasma at 25°C (A) and 37°C (B) measured by the enzyme kinetics method. Each point represents mean values of experiments performed in triplicate. Percentage values varied less than ±5% between determinations.

3 Stability of EPC/Chol (□), EPC/Chol/SM (○), EPC/Chol/SM/GM1 (♦), and EPC/Chol/SM/GM type III (▾) liposomes in acid media, pH: 2 at 37°C measured by BSA retained. Each point represents mean values of experiments performed in triplicate. Percentage values varied less than ±7% between determinations.

3 Stability of EPC/Chol (□), EPC/Chol/SM (○), EPC/Chol/SM/GM1 (♦), and EPC/Chol/SM/GM type III (▾) liposomes in acid media, pH: 2 at 37°C measured by BSA retained. Each point represents mean values of experiments performed in triplicate. Percentage values varied less than ±7% between determinations.

4 Stability of EPC/Chol (□), EPC/Chol/SM (○), EPC/Chol/SM/GM1 (♦), and EPC/Chol/SM/GM type III (▾) liposomes in bile (A) and pancreatin (B), incubated at 37°C, measured by the enzyme kinetics method. Each point represents mean values of experiments performed in triplicate. Percentage values varied less than ±5% between determinations.

4 Stability of EPC/Chol (□), EPC/Chol/SM (○), EPC/Chol/SM/GM1 (♦), and EPC/Chol/SM/GM type III (▾) liposomes in bile (A) and pancreatin (B), incubated at 37°C, measured by the enzyme kinetics method. Each point represents mean values of experiments performed in triplicate. Percentage values varied less than ±5% between determinations.

5 Comparative stability of release percentage in different formulations. Column 1: EPC/Chol, column 2: EPC/Chol/SM, column 3: EPC/Chol/SM/GM1, and column 4: EPC/Chol/SM/ GM type III. Each column represents the percentage of drug released after 3 hr in acid pH (), bile (), and pancreatin (). Incubations were carried out at 37°C.

5 Comparative stability of release percentage in different formulations. Column 1: EPC/Chol, column 2: EPC/Chol/SM, column 3: EPC/Chol/SM/GM1, and column 4: EPC/Chol/SM/ GM type III. Each column represents the percentage of drug released after 3 hr in acid pH (), bile (), and pancreatin (). Incubations were carried out at 37°C.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.